Filing Flows › Spero Therapeutics (SPRO) › How it makes money
How Spero Therapeutics (SPRO) makes money
Spero Therapeutics (SPRO) made $258K of revenue in the first quarter 2026 (Q1 2026), -96% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 2026 | % of revenue |
|---|---|---|
| Revenue | $258K | 100.0% |
| Operating cash flow | $15.9M | n/m |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 2026 | $258K | -96% |
| Q4 2025 | $41.3M | +174% |
| Q3 2025 | $5.4M | -60% |
| Q2 2025 | $14.2M | +39% |
| Q1 2025 | $5.9M | -37% |
| Q4 2024 | $15.0M | -80% |
From Spero Therapeutics' 10-Q filed May 13, 2026 (on EDGAR).
Questions
How does Spero Therapeutics make money?
Spero Therapeutics (SPRO) made $258K of revenue in the first quarter 2026 (Q1 2026), -96% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.